Julia R Dahlqvist1, Grete Andersen2, Tahmina Khawajazada2, Christoffer Vissing2, Carsten Thomsen3, John Vissing2. 1. Section 3342, Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen University, Blegdamsvej 9, 2100, Copenhagen, Denmark. julia.rebecka.dahlqvist@regionh.dk. 2. Section 3342, Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen University, Blegdamsvej 9, 2100, Copenhagen, Denmark. 3. Department of Radiology, Rigshospitalet, Copenhagen University, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Abstract
OBJECTIVE: Unlike most muscular dystrophies that progress symmetrically at a constant rate, facioscapulohumeral muscular dystrophy (FSHD) is characterized by stepwise, asymmetric progression of muscle wasting, and weakness. Muscle tissue is progressively replaced by fat; however, its relation to preceding inflammation is unclear. In this longitudinal study of FSHD, we assessed muscle inflammation and fat replacement and their relation quantitatively. We also investigated whether fat replacement in muscle varies along its length. METHODS: Forty-five patients with FSHD were evaluated twice, 14 months apart. Using MRI sequences with short TI inversion recovery (STIR), we quantified the degree of STIR hyperintensity in muscles (≥ 2 SD above control intensity). STIR hyperintensities (STIR+) suggest edema or inflammation. We used Dixon MRI to quantify fat content. RESULTS: Of 370 thigh muscles, 83 were STIR+ at baseline and 103 at follow-up. The highest frequency of STIR+ was seen in muscles with inter-mediate fat content (40-60% fat). The progression of fat replacement was higher in STIR+ muscles (5.0 ± 4.0%) vs. STIR- muscles [2.3 ± 3.3% (P < 0.0001)]. In addition, muscles with severe STIR+ at baseline had a higher fat replacement progression than muscles with milder STIR+ (R = 0.39, P = 0.001). The fat content was higher in the distal part vs. proximal part of most muscles (P < 0.05). However, the progression of the fat replacement was uniform along the length of all the muscles. CONCLUSION: Muscles with STIR+, indicating inflammation, have a faster progression of fat replacement than STIR- muscles, and the fat replacement progression correlated with the severity of STIR+.
OBJECTIVE: Unlike most muscular dystrophies that progress symmetrically at a constant rate, facioscapulohumeral muscular dystrophy (FSHD) is characterized by stepwise, asymmetric progression of muscle wasting, and weakness. Muscle tissue is progressively replaced by fat; however, its relation to preceding inflammation is unclear. In this longitudinal study of FSHD, we assessed muscle inflammation and fat replacement and their relation quantitatively. We also investigated whether fat replacement in muscle varies along its length. METHODS: Forty-five patients with FSHD were evaluated twice, 14 months apart. Using MRI sequences with short TI inversion recovery (STIR), we quantified the degree of STIR hyperintensity in muscles (≥ 2 SD above control intensity). STIR hyperintensities (STIR+) suggest edema or inflammation. We used Dixon MRI to quantify fat content. RESULTS: Of 370 thigh muscles, 83 were STIR+ at baseline and 103 at follow-up. The highest frequency of STIR+ was seen in muscles with inter-mediate fat content (40-60% fat). The progression of fat replacement was higher in STIR+ muscles (5.0 ± 4.0%) vs. STIR- muscles [2.3 ± 3.3% (P < 0.0001)]. In addition, muscles with severe STIR+ at baseline had a higher fat replacement progression than muscles with milder STIR+ (R = 0.39, P = 0.001). The fat content was higher in the distal part vs. proximal part of most muscles (P < 0.05). However, the progression of the fat replacement was uniform along the length of all the muscles. CONCLUSION: Muscles with STIR+, indicating inflammation, have a faster progression of fat replacement than STIR- muscles, and the fat replacement progression correlated with the severity of STIR+.
Authors: Chao-Jen Wong; Leo Wang; V Michael Holers; Ashley Frazer-Abel; Silvère M van der Maarel; Rabi Tawil; Jeffrey M Statland; Stephen J Tapscott Journal: Hum Mol Genet Date: 2022-06-04 Impact factor: 5.121
Authors: Leo H Wang; Laura M Johnstone; Michael Bindschadler; Stephen J Tapscott; Seth D Friedman Journal: BMC Musculoskelet Disord Date: 2021-01-09 Impact factor: 2.362
Authors: Anita van den Heuvel; Saskia Lassche; Karlien Mul; Anna Greco; David San León Granado; Arend Heerschap; Benno Küsters; Stephen J Tapscott; Nicol C Voermans; Baziel G M van Engelen; Silvère M van der Maarel Journal: Sci Rep Date: 2022-01-26 Impact factor: 4.379
Authors: Saskia Lassche; Nicol C Voermans; Tim Schreuder; Arend Heerschap; Benno Küsters; Coen Ac Ottenheijm; Maria Te Hopman; Baziel Gm van Engelen Journal: Muscle Nerve Date: 2020-10-15 Impact factor: 3.217
Authors: Teresa Gerhalter; Benjamin Marty; Lena V Gast; Katharina Porzelt; Rafael Heiss; Michael Uder; Stefan Schwab; Pierre G Carlier; Armin M Nagel; Matthias Türk Journal: J Neurol Date: 2020-10-12 Impact factor: 4.849
Authors: Leo H Wang; Dennis W W Shaw; Anna Faino; Christopher B Budech; Leann M Lewis; Jeffrey Statland; Katy Eichinger; Stephen J Tapscott; Rabi N Tawil; Seth D Friedman Journal: BMC Musculoskelet Disord Date: 2021-03-10 Impact factor: 2.362